Literature DB >> 8733047

First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas).

J C Oosterwijk1, J C Jansen, E M van Schothorst, A W Oosterhof, P Devilee, E Bakker, M W Zoeteweij, A G van der Mey.   

Abstract

Hereditary glomus tumour (MIM 168,000) or paraganglioma (PGL) is a slowly progressive disorder causing benign tumour growth predominantly in the head and neck region. Though benign in nature the tumours can lead to severe morbidity. Inheritance of PGL is autosomal dominant and is strongly modified by genomic imprinting; only a paternally transmitted PGL gene leads to symptoms. A gene for PGL has recently been mapped to 11q22.3-q23. Genetic counselling on the basis of DNA linkage diagnosis was offered in an extended Dutch pedigree. Thirty-two subjects opted for further counselling, of whom 20 applied for DNA testing and participated in a standardised protocol. Sixteen cases had presymptomatic testing (paternal allele); four of these appeared to have the at risk haplotype and in two of them a glomus tumour was subsequently detected on MRI. In one case linkage results were inconclusive (recombination) and one person did not want to learn his test result. Four cases had testing for carrier status (maternal allele) of which one appeared to be a carrier. Our data show that genetic counselling gains significant accuracy when based on parent of origin, sex of the counsellee, and DNA linkage diagnosis. Moreover, a normal DNA result may prevent unnecessary worry and investigations, while an established presymptomatic diagnosis will guide adequate clinical management. The psychological impact of counselling and predictive DNA testing is unclear as yet. Further investigations into the natural history of PGL in gene carriers and into the psychological impact of DNA testing is desirable.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8733047      PMCID: PMC1050606          DOI: 10.1136/jmg.33.5.379

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

1.  DNA-testing for Huntington's disease in The Netherlands: a retrospective study on psychosocial effects.

Authors:  A Tibben; M Vegter-van der Vlis; M I Skraastad; P G Frets; J J van der Kamp; M F Niermeijer; G J van Ommen; R A Roos; H G Rooijmans; D Stronks
Journal:  Am J Med Genet       Date:  1992-09-01

Review 2.  Genomic imprinting and cancer.

Authors:  A C Ferguson-Smith; W Reik; M A Surani
Journal:  Cancer Surv       Date:  1990

Review 3.  Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory.

Authors:  A G van der Mey; P D Maaswinkel-Mooy; C J Cornelisse; P H Schmidt; J J van de Kamp
Journal:  Lancet       Date:  1989-12-02       Impact factor: 79.321

4.  Genetic aspects of nonchromaffin paraganglioma.

Authors:  F van Baars; C Cremers; P van den Broek; S Geerts; J Veldman
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

5.  Paragangliomas of the head and neck region: a clinical study of 69 patients.

Authors:  E E Lack; A L Cubilla; J M Woodruff; H W Farr
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

Review 6.  Familial carotid body tumors: case report and epidemiologic review.

Authors:  S Grufferman; M W Gillman; L R Pasternak; C L Peterson; W G Young
Journal:  Cancer       Date:  1980-11-01       Impact factor: 6.860

7.  Further localization of the gene for hereditary paragangliomas and evidence for linkage in unrelated families.

Authors:  P Heutink; E M van Schothorst; A G van der Mey; A Bardoel; G Breedveld; J Pertijs; L A Sandkuijl; G J van Ommen; C J Cornelisse; B A Oostra
Journal:  Eur J Hum Genet       Date:  1994       Impact factor: 4.246

8.  Carotid body tumors: a subject review and suggested surgical approach.

Authors:  F B Meyer; T M Sundt; B W Pearson
Journal:  J Neurosurg       Date:  1986-03       Impact factor: 5.115

9.  Familiar non-chromaffinic paragangliomas (glomus tumors). Clinical and genetic aspects (abridged).

Authors:  F M van Baars; C W Cremers; P van den Broek; J E Veldman
Journal:  Acta Otolaryngol       Date:  1981 May-Jun       Impact factor: 1.494

10.  MRI screening of kindred at risk of developing paragangliomas: support for genomic imprinting in hereditary glomus tumours.

Authors:  A P van Gils; A G van der Mey; R P Hoogma; L A Sandkuijl; P D Maaswinkel-Mooy; T H Falke; E K Pauwels
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

View more
  9 in total

1.  Evolving concepts in the management of jugular paraganglioma: a comparison of radiotherapy and surgery in 88 cases.

Authors:  Patrice Tran Ba Huy; Romain Kania; Michèle Duet; Bernadette Dessard-Diana; Jean-Jacques Mazeron; Rania Benhamed
Journal:  Skull Base       Date:  2009-01

Review 2.  Imaging and management of head and neck paragangliomas.

Authors:  René van den Berg
Journal:  Eur Radiol       Date:  2005-04-05       Impact factor: 5.315

3.  p53 and p16INK4A mutations during the progression of glomus tumor.

Authors:  S Güran; E T Tali
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

4.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.

Authors:  A P Gimenez-Roqueplo; J Favier; P Rustin; J J Mourad; P F Plouin; P Corvol; A Rötig; X Jeunemaitre
Journal:  Am J Hum Genet       Date:  2001-10-16       Impact factor: 11.025

Review 5.  Hereditary paraganglioma targets diverse paraganglia.

Authors:  B E Baysal
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

6.  Founder effect at PGL1 in hereditary head and neck paraganglioma families from the Netherlands.

Authors:  E M van Schothorst; J C Jansen; E Grooters; D E Prins; J J Wiersinga; A G van der Mey; G J van Ommen; P Devilee; C J Cornelisse
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

7.  The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family.

Authors:  Erik F Hensen; Jeroen C Jansen; Maaike D Siemers; Jan C Oosterwijk; Annette Hjt Vriends; Eleonora Pm Corssmit; Jean-Pierre Bayley; Andel Gl van der Mey; Cees J Cornelisse; Peter Devilee
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

8.  A case of carotid body paraganglioma and haemangioblastoma of the spinal cord in a patient with the N131K missense mutation in the VHL gene.

Authors:  Krzysztof Majchrzak; Cezary Cybulski; Barbara Bobek-Billewicz; Henryk Majchrzak; Jan Lubiński
Journal:  Neurol Sci       Date:  2011-03-08       Impact factor: 3.307

9.  The effect of preoperative embolization on surgical outcomes for carotid body tumor resection.

Authors:  Robin Osofsky; Ross Clark; Jaideep Das Gupta; Nathan Boyd; Garth Olson; LeAnn Chavez; Sundeep Guliani; Mark Langsfeld; John Marek; Muhammad Ali Rana
Journal:  SAGE Open Med       Date:  2021-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.